InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

0.5199
Delayed Data
As of Feb 16
 +0.0072 / +1.40%
Today’s Change
0.45
Today|||52-Week Range
4.60
-32.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-38.8M-18.3M-33.3M-23.4M
 
 
 
 
 
Depreciation740.7K752.0K689.0K553.0K
 
 
 
 
 
Total Other Cash Flow23.0M3.8M15.7M4.8M
 
 
 
 
 
Funds From Operations-15.1M-13.8M-17.0M-18.1M
 
 
 
 
 
Funds From/For Other Operating Expenses-145.8K1.6M-564.0K-1.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-14.9M-15.5M-16.4M-16.7M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.000.00-18.9M
 
 
Decrease In Investments0.000.000.0012.5M
 
 
Capital Expenditures-748.5K-47.0K-5.0K-107.0K
 
 
 
 
 
Fixed Asset Disposal--45.0K0.000.00
 
 
Net Cash Flow Investing-748.5K-2.0K-5.0K-6.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings491.8K0.000.00--
 
 
Long Term Debt Reduction-89.9K-77.0K-268.0K-395.0K
 
 
 
 
 
Net Proceeds Stock Sale16.4M14.8M23.3M30.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing16.8M14.8M23.1M29.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash1.2M-701.0K6.7M6.5M